Cargando…
Investigating the genomic landscape of novel coronavirus (2019-nCoV) to identify non-synonymous mutations for use in diagnosis and drug design
Novel coronavirus has wrecked medical and health care facilities claiming ∼5% death tollsglobally. All efforts to contain the pathogenesis either using inhibitory drugs or vaccines largelyremained futile due to a lack of better understanding of the genomic feature of this virus. In thepresent study,...
Autores principales: | Tiwari, Manish, Mishra, Divya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227581/ https://www.ncbi.nlm.nih.gov/pubmed/32425659 http://dx.doi.org/10.1016/j.jcv.2020.104441 |
Ejemplares similares
-
Return of the Coronavirus: 2019-nCoV
por: Gralinski, Lisa E., et al.
Publicado: (2020) -
2019 Novel Coronavirus (2019-nCoV) Pneumonia
por: Liu, Peng, et al.
Publicado: (2020) -
Containing 2019-nCoV (Wuhan) coronavirus
por: Kaplan, Edward H.
Publicado: (2020) -
Novel Coronavirus (2019-nCoV) in Disguise
por: Zhang, Qian, et al.
Publicado: (2020) -
Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia
por: Song, Fengxiang, et al.
Publicado: (2020)